| MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS PF O’Reilly, CJ Hoggart, Y Pomyen, FCF Calboli, P Elliott, MR Jarvelin, ... PloS one 7 (5), e34861, 2012 | 423 | 2012 |
| Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma J Chaisaingmongkol, A Budhu, H Dang, S Rabibhadana, B Pupacdi, ... Cancer cell 32 (1), 57-70. e3, 2017 | 381 | 2017 |
| Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma H Zheng, Y Pomyen, MO Hernandez, C Li, F Livak, W Tang, H Dang, ... Hepatology 68 (1), 127-140, 2018 | 308 | 2018 |
| Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma H Dang, A Takai, M Forgues, Y Pomyen, H Mou, W Xue, D Ray, KCH Ha, ... Cancer cell 32 (1), 101-114. e8, 2017 | 143 | 2017 |
| Deep metabolome: Applications of deep learning in metabolomics Y Pomyen, K Wanichthanarak, P Poungsombat, J Fahrmann, D Grapov, ... Computational and Structural Biotechnology Journal 18, 2818-2825, 2020 | 139 | 2020 |
| Genome-wide CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice CQ Song, Y Li, H Mou, J Moore, A Park, Y Pomyen, S Hough, Z Kennedy, ... Gastroenterology 152 (5), 1161-1173. e1, 2017 | 131 | 2017 |
| Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells C Koufaris, GN Valbuena, Y Pomyen, GD Tredwell, E Nevedomskaya, ... Oncogene 35 (21), 2766-2776, 2016 | 69 | 2016 |
| Understanding the cause and consequence of tumor heterogeneity S Khatib, Y Pomyen, H Dang, XW Wang Trends in cancer 6 (4), 267-271, 2020 | 39 | 2020 |
| Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization V Fako, SP Martin, Y Pomyen, A Budhu, J Chaisaingmongkol, S Franck, ... International Journal of Biological Sciences 15 (12), 2654, 2019 | 24 | 2019 |
| Over-representation of correlation analysis (ORCA): a method for identifying associations between variable sets Y Pomyen, M Segura, TMD Ebbels, HC Keun Bioinformatics 31 (1), 102-108, 2015 | 20 | 2015 |
| AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma K Zhang, Y Pomyen, AE Barry, SP Martin, S Khatib, L Knight, M Forgues, ... Molecular Cancer Research 18 (4), 612-622, 2020 | 19 | 2020 |
| Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma Y Pomyen, J Chaisaingmongkol, S Rabibhadana, B Pupacdi, D Sripan, ... Scientific Reports 13 (1), 11406, 2023 | 16 | 2023 |
| NELFE-dependent MYC signature identifies a unique cancer subtype in hepatocellular carcinoma H Dang, Y Pomyen, SP Martin, DA Dominguez, SY Yim, JS Lee, A Budhu, ... Scientific reports 9 (1), 3369, 2019 | 16 | 2019 |
| Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma Y Pomyen, A Budhu, J Chaisaingmongkol, M Forgues, H Dang, ... Scientific Reports 11 (1), 12097, 2021 | 10 | 2021 |
| Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker K Anekthanakul, S Manocheewa, K Chienwichai, P Poungsombat, ... Iscience 24 (11), 2021 | 9 | 2021 |
| Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis S Chujan, T Suriyo, T Ungtrakul, Y Pomyen, J Satayavivad Biomedical Reports 9 (1), 42-52, 2018 | 5 | 2018 |
| Quantifying fecal and plasma short-chain fatty acids in healthy Thai individuals W Manokasemsan, N Jariyasopit, P Poungsombat, K Kaewnarin, ... Computational and Structural Biotechnology Journal 23, 2163-2172, 2024 | 3 | 2024 |
| Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma Z Kacar, E Slud, D Levy, J Candia, A Budhu, M Forgues, X Wu, ... Communications Biology 7 (1), 383, 2024 | 3 | 2024 |
| CAIM: coverage-based analysis for identification of microbiome DA Acheampong, P Jenjaroenpun, T Wongsurawat, A Kurilung, ... Briefings in Bioinformatics 25 (5), bbae424, 2024 | 1 | 2024 |
| Identification of autoantibodies as potential non-invasive biomarkers for intrahepatic cholangiocarcinoma W Kajornsrichon, J Chaisaingmongkol, Y Pomyen, P Tit-Oon, XW Wang, ... Scientific Reports 14 (1), 20012, 2024 | | 2024 |
